TNF and cancer: In some instances, SM administration not only induces a reversion of tumor-associated macrophages from a protumorous M2 phenotype to a proinflammatory M1-like phenotype170 but also sensitizes resistant cancer cells to inactivate by an inflammatory burst of TNF and IFN-γ171–173.